Getting Older and Illness | Sale!

From October 26, 2026 eNewsletter

DID YOU KNOW that nicotinamide, also known as niacinamide, a non-flush form of niacin, has been populating numerous research journals recently?

Oral nicotinamide was cost-effective for reducing keratinocyte carcinoma (KC) risk in US veterans with a history of the disease, according to findings in JAMA Dermatology. The authors “support strong consideration of nicotinamide for KC prevention in high-risk populations like veterans, particularly given its safety and tolerability."

Nicotinamide supplementation was associated with a decreased risk for melanoma among patients with a history of other skin cancers, according to a study presented at the American Academy of Dermatology 2026 Annual Meeting.

Researchers publishing in Metabolism: Clinical and Experimental found that niacinamide helped those with metabolic-associated fatty liver disease. By uncoupling negative expression of a key gene, niacinamide helped restore normal fat-processing pathways in the liver and improved overall lipid balance.

To read the rest of today's issue, please go to this page.